- Home
- Publications
- Publication Search
- Publication Details
Title
Renin angiotensin system in liver diseases: Friend or foe?
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 23, Issue 19, Pages 3396
Publisher
Baishideng Publishing Group Inc.
Online
2017-05-20
DOI
10.3748/wjg.v23.i19.3396
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hepatorenal syndrome
- (2016) Natasha Shah et al. DM DISEASE-A-MONTH
- Renin–angiotensin system inhibitors and fibrosis in chronic liver disease: a systematic review
- (2016) Gaeun Kim et al. Hepatology International
- Therapeutic effect of renin angiotensin system inhibitors on liver fibrosis
- (2016) Qianqian Zhu et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Lipid disorder and intrahepatic renin-angiotensin system activation synergistically contribute to non-alcoholic fatty liver disease
- (2016) Yu Wu et al. LIVER INTERNATIONAL
- ACE inhibition, ACE2 and angiotensin-(17) axis in kidney and cardiac inflammation and fibrosis
- (2016) Ana Cristina Simões e Silva et al. PHARMACOLOGICAL RESEARCH
- Role of renin-angiotensin system in liver diseases: an outline on the potential therapeutic points of intervention
- (2016) Elham Ahmadian et al. Expert Review of Gastroenterology & Hepatology
- Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease
- (2016) Serena Pelusi et al. PLoS One
- Angiotensin-converting enzyme 2/angiotensin-(1–7)/Mas axis activates Akt signaling to ameliorate hepatic steatosis
- (2016) Xi Cao et al. Scientific Reports
- Pleiotropic Effects of Angiotensin II Receptor Signaling in Cardiovascular Homeostasis and Aging
- (2015) Takehiro Kamo et al. International Heart Journal
- ACE2 Therapy Using Adeno-associated Viral Vector Inhibits Liver Fibrosis in Mice
- (2015) Kai Y Mak et al. MOLECULAR THERAPY
- Emerging Liver–Kidney Interactions in Nonalcoholic Fatty Liver Disease
- (2015) Giovanni Musso et al. TRENDS IN MOLECULAR MEDICINE
- ACE2: Angiotensin II/Angiotensin-(1–7) Balance in Cardiac and Renal Injury
- (2014) Jasmina Varagic et al. CURRENT HYPERTENSION REPORTS
- Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis
- (2014) Michaela Granzow et al. HEPATOLOGY
- The global burden of liver disease: The major impact of China
- (2014) Fu-Sheng Wang et al. HEPATOLOGY
- Renin-angiotensin system and fibrosis in non-alcoholic fatty liver disease
- (2014) George B Goh et al. LIVER INTERNATIONAL
- The ACE2/Ang-(1–7)/Mas axis can inhibit hepatic insulin resistance
- (2014) Xi Cao et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The role of renin-angiotensin system modulation on treatment and prevention of liver diseases
- (2014) Simone Moreira de Macêdo et al. PEPTIDES
- Nonalcoholic fatty liver disease and the renin-angiotensin system blockers in the patients with chronic kidney disease
- (2014) Lidija Orlic et al. WIENER KLINISCHE WOCHENSCHRIFT
- ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis
- (2013) AC Simões e Silva et al. BRITISH JOURNAL OF PHARMACOLOGY
- Activation of the Mas Receptor by Angiotensin-(1–7) in the Renin–Angiotensin System Mediates Mesenteric Vasodilatation in Cirrhosis
- (2013) Josephine A. Grace et al. GASTROENTEROLOGY
- Oral Formulation of Angiotensin-(1–7) Improves Lipid Metabolism and Prevents High-Fat Diet–Induced Hepatic Steatosis and Inflammation in Mice
- (2013) John David Feltenberger et al. HYPERTENSION
- Oral Angiotensin-(1–7) prevented obesity and hepatic inflammation by inhibition of resistin/TLR4/MAPK/NF-κB in rats fed with high-fat diet
- (2013) Sérgio Henrique Sousa Santos et al. PEPTIDES
- Beneficial Effects of the Activation of the Angiotensin-(1–7) Mas Receptor in a Murine Model of Adriamycin-Induced Nephropathy
- (2013) Kátia Daniela Silveira et al. PLoS One
- Up-regulation of components of the renin–angiotensin system in liver fibrosis in the rat induced by CCL4
- (2013) Wei Zhang et al. RESEARCH IN VETERINARY SCIENCE
- Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
- (2013) Takumi Hirata et al. International Journal of Endocrinology
- Update on new aspects of the renin–angiotensin system in liver disease: clinical implications and new therapeutic options
- (2012) Josephine A. Grace et al. CLINICAL SCIENCE
- Blockade of the renin–angiotensin system improves the early stages of liver regeneration and liver function
- (2012) Shir Lin Koh et al. JOURNAL OF SURGICAL RESEARCH
- Serum angiotensin-converting enzyme level as a marker of fibrosis in patients with chronic hepatitis B
- (2012) Tugrul Purnak et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- The renin–angiotensin–aldosterone system in 2011: role in hypertension and chronic kidney disease
- (2011) Ana Cristina Simões e Silva et al. PEDIATRIC NEPHROLOGY
- Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
- (2010) Giovanni Musso et al. ANNALS OF MEDICINE
- PKA-mediated effect of MAS receptor in counteracting angiotensin II-stimulated renal Na+-ATPase
- (2010) Lucienne S. Lara et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Phase I and Pharmacokinetic Study of Angiotensin-(1-7), an Endogenous Antiangiogenic Hormone
- (2009) W. J. Petty et al. CLINICAL CANCER RESEARCH
- Angiotensin-(1–7), an alternative metabolite of the renin–angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat
- (2009) John S. Lubel et al. CLINICAL SCIENCE
- Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice
- (2009) Christoph H. Österreicher et al. HEPATOLOGY
- Devil and angel in the renin–angiotensin system: ACE–angiotensin II–AT1 receptor axis vs. ACE2–angiotensin-(1–7)–Mas receptor axis
- (2009) Masaru Iwai et al. HYPERTENSION RESEARCH
- The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C
- (2009) Kathleen E. Corey et al. LIVER INTERNATIONAL
- Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis
- (2009) Walkíria Wingester Vilas-Boas et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Renin-angiotensin system in the pathogenesis of liver fibrosis
- (2009) Regina Maria Pereira et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis
- (2008) Robson A. S. Santos et al. EXPERIMENTAL PHYSIOLOGY
- Liver disease and the renin-angiotensin system: Recent discoveries and clinical implications
- (2008) John S Lubel et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis
- (2008) Paolo Angeli et al. JOURNAL OF HEPATOLOGY
- Pathogenesis and Treatment of Hepatorenal Syndrome
- (2008) Vicente Arroyo et al. SEMINARS IN LIVER DISEASE
- Development of hepatorenal syndrome in bile duct ligated rats
- (2008) Regina M Pereira et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Effect of propranolol on the splanchnic and peripheral renin angiotensin system in cirrhotic patients
- (2008) Walkíria Wingester Vilas-Boas et al. WORLD JOURNAL OF GASTROENTEROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started